We are live on ! Find out more
CRVS icon

Corvus Pharmaceuticals

54 hedge funds and large institutions have $280M invested in Corvus Pharmaceuticals in 2017 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 19 increasing their positions, 16 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 3

32% more capital invested

Capital invested by funds: $212M → $280M (+$67.9M)

19% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 16

4% more funds holding

Funds holding: 5254 (+2)

0.19% more ownership

Funds ownership: 83.59%83.78% (+0.19%)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

Holders
54
Holders Change
+2
Holders Change %
+3.85%
% of All Funds
1.35%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
6
Increased
19
Reduced
16
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
AIP
51
Ameritas Investment Partners
Nebraska
$4K
IP
52
Intellectus Partners
California
$1K -$19.3K -1,392 -94%
MAM
53
Meeder Asset Management
Ohio
$1K -$5.38K -389 -83%
TD Asset Management
54
TD Asset Management
Ontario, Canada
-$130K -10,744 Closed
MF
55
Magnetar Financial
Illinois
-$128K -10,613 Closed
PHK
56
Point72 Hong Kong
Hong Kong
-$6K -527 Closed
Citigroup
57
Citigroup
New York
-$761 -55 -98%